{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:00:27Z","timestamp":1784815227500,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital Linkou Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3I0071\u223c3"],"award-info":[{"award-number":["CMRPG3I0071\u223c3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3K0421"],"award-info":[{"award-number":["CMRPG3K0421"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajo.2021.06.034","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T10:50:57Z","timestamp":1626519057000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cognitive Outcomes Following Intravitreal Bevacizumab for Retinopathy of Prematurity: 4- to 6-Year Outcomes in a Prospective Cohort"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-3059","authenticated-orcid":false,"given":"Hung-Da","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Pang","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-3172","authenticated-orcid":false,"given":"Laura","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-3234","authenticated-orcid":false,"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-7255","authenticated-orcid":false,"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2021.06.034_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"issue":"8","key":"10.1016\/j.ajo.2021.06.034_bib0002","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1167\/iovs.18-24020","article-title":"Retinopathy of prematurity trends in Taiwan: a 10-year nationwide population study","volume":"59","author":"Kang","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2021.06.034_bib0003","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ajo.2021.06.034_bib0004","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2021.06.034_bib0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2021.06.034_bib0006","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajo.2021.06.034_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","article-title":"Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment","volume":"192","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2021.06.034_bib0008","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1097\/IAE.0000000000002684","article-title":"Ten-year epidemiology of retinopathy of prematurity treatment in Taiwan","volume":"40","author":"Kang","year":"2020","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0009","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.06.034_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0011","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/dev.114.2.521","article-title":"Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation","volume":"114","author":"Breier","year":"1992","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1523\/JNEUROSCI.4445-12.2013","article-title":"Neurogenesis continues in the third trimester of pregnancy and is suppressed by premature birth","volume":"33","author":"Malik","year":"2013","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.ajo.2021.06.034_bib0013","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity\u2014a meta-analysis","volume":"128","author":"Tsai","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpeds.2012.01.057","article-title":"Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes","volume":"161","author":"Vohr","year":"2012","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/13854046.2016.1216518","article-title":"Assessing developmental delay in early childhood\u2014concerns with the Bayley-III scales","volume":"31","author":"Anderson","year":"2017","journal-title":"Clin Neuropsychol"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0016","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/IAE.0b013e318275394a","article-title":"Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up","volume":"33","author":"Martinez-Castellanos","year":"2013","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2021.06.034_bib0017","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1469-8749.2011.04181.x","article-title":"Prediction of cognitive abilities at the age of 5 years using developmental follow-up assessments at the age of 2 and 3 years in very preterm children","volume":"54","author":"Potharst","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.ajo.2021.06.034_bib0018","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.DBP.0000452240.39511.d4","article-title":"Neurodevelopmental outcomes of infants born prematurely","volume":"35","author":"Aylward","year":"2014","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"10.1016\/j.ajo.2021.06.034_bib0019","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","article-title":"Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan","volume":"118","author":"Wu","year":"2011","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2021.06.034_bib0020","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/IAE.0000000000002663","article-title":"Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti-vascular endothelial growth factor monotherapy","volume":"40","author":"Ling","year":"2020","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2021.06.034_bib0021","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5535\/arm.2017.41.5.851","article-title":"The validity of the Bayley-III and DDST-II in preterm infants with neurodevelopmental impairment: a pilot study","volume":"41","author":"Jeong","year":"2017","journal-title":"Ann Rehabil Med"},{"issue":"4","key":"10.1016\/j.ajo.2021.06.034_bib0022","doi-asserted-by":"crossref","first-page":"e794","DOI":"10.1542\/peds.2011-0331","article-title":"Overestimating neurodevelopment using the Bayley-III after early complex cardiac surgery","volume":"128","author":"Acton","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ajo.2021.06.034_bib0023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0734282913508620","article-title":"Test review: Wechsler Preschool and Primary Scale of Intelligence\u2013fourth edition","volume":"32","author":"Syeda","year":"2014","journal-title":"J Psychoeduc Assess"},{"issue":"4","key":"10.1016\/j.ajo.2021.06.034_bib0024","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ajo.2021.06.034_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230678","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity","volume":"15","author":"Arima","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ajo.2021.06.034_bib0026","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.ophtha.2017.05.007","article-title":"Re: Good: Bevacizumab for retinopathy of prematurity: Treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844)","volume":"124","author":"Blair","year":"2017","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2021.06.034_bib0027","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","article-title":"Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study","volume":"126","author":"Fan","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0028","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3537","article-title":"Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment","volume":"144","author":"Natarajan","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2021.06.034_bib0029","article-title":"Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment","volume":"31","author":"Rodriguez","year":"2020","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.ajo.2021.06.034_bib0030","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1055\/s-0040-1710556","article-title":"Bevacizumab for retinopathy of prematurity: 2-year neurodevelopmental follow-up","volume":"38","author":"Zayek","year":"2021","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.ajo.2021.06.034_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148019","article-title":"Neurodevelopmental outcomes in infants with retinopathy of prematurity and bevacizumab treatment","volume":"11","author":"Lien","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajo.2021.06.034_bib0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","article-title":"Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity","volume":"22","author":"Kennedy","year":"2018","journal-title":"J AAPOS"},{"issue":"9","key":"10.1016\/j.ajo.2021.06.034_bib0033","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41372-019-0420-z","article-title":"Neurodevelopmental outcomes in infants treated with intravitreal bevacizumab versus laser","volume":"39","author":"Raghuram","year":"2019","journal-title":"J Perinatol"},{"issue":"10","key":"10.1016\/j.ajo.2021.06.034_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223972","article-title":"Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ajo.2021.06.034_bib0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/02713683.2014.941070","article-title":"Preliminary anatomical and neurodevelopmental outcomes of intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity","volume":"40","author":"Araz-Ersan","year":"2015","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2021.06.034_bib0036","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3928\/23258160-20200326-03","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab with laser versus laser photocoagulation alone for retinopathy of prematurity","volume":"51","author":"Ahmed","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"10.1016\/j.ajo.2021.06.034_bib0037","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3928\/23258160-20180129-07","article-title":"Outcomes of intravitreal bevacizumab and diode laser photocoagulation for treatment-warranted retinopathy of prematurity","volume":"49","author":"Chen","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"6","key":"10.1016\/j.ajo.2021.06.034_bib0038","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.288.6.728","article-title":"Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis","volume":"288","author":"Bhutta","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2021.06.034_bib0039","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2016.02.048","article-title":"Girls and boys born before 28 weeks gestation: risks of cognitive, behavioral, and neurologic outcomes at age 10 years","volume":"173","author":"Kuban","year":"2016","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ajo.2021.06.034_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/archdischild-2017-313414","article-title":"Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation: a prospective, population-based cohort study","volume":"103","author":"Linsell","year":"2018","journal-title":"Arch Dis Child"},{"issue":"12","key":"10.1016\/j.ajo.2021.06.034_bib0041","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S2352-4642(18)30287-6","article-title":"Changes in long-term prognosis with increasing postnatal survival and the occurrence of postnatal morbidities in extremely preterm infants offered intensive care: a prospective observational study","volume":"2","author":"Cheong","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"10.1016\/j.ajo.2021.06.034_bib0042","doi-asserted-by":"crossref","first-page":"F235","DOI":"10.1136\/archdischild-2016-311228","article-title":"Determinants of developmental outcomes in a very preterm Canadian cohort","volume":"102","author":"Synnes","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"10.1016\/j.ajo.2021.06.034_bib0043","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/dmcn.13380","article-title":"Neonatal predictors of cognitive ability in adults born very preterm: a prospective cohort study","volume":"59","author":"Breeman","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.ajo.2021.06.034_bib0044","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1076\/jcen.21.6.851.859","article-title":"Long-term neuropsychological outcomes in very low birth weight children free of sensorineural impairments","volume":"21","author":"Dewey","year":"1999","journal-title":"J Clin Exp Neuropsychol"},{"issue":"7","key":"10.1016\/j.ajo.2021.06.034_bib0045","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1017\/S0033291713002158","article-title":"Extremely preterm birth and adolescent mental health in a geographical cohort born in the 1990s","volume":"44","author":"Burnett","year":"2014","journal-title":"Psychol Med"},{"issue":"10","key":"10.1016\/j.ajo.2021.06.034_bib0046","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jamapediatrics.2016.1210","article-title":"Neurodevelopmental outcomes among extremely preterm infants 6.5 years after active perinatal care in Sweden","volume":"170","author":"Serenius","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"6","key":"10.1016\/j.ajo.2021.06.034_bib0047","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jama.289.6.705","article-title":"Change in cognitive function over time in very low-birth-weight infants","volume":"289","author":"Ment","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2021.06.034_bib0048","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fphys.2019.00307","article-title":"Cognitive development trajectories in preterm children with very low birth weight longitudinally followed until 11 years of age","volume":"10","author":"St\u00e5lnacke","year":"2019","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.ajo.2021.06.034_bib0049","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4009","article-title":"Are neurodevelopmental outcomes of infants born extremely preterm improving over time?","volume":"141","author":"Doyle","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ajo.2021.06.034_bib0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpeds.2014.12.016","article-title":"Social variables predict gains in cognitive scores across the preschool years in children with birth weights 500 to 1250 grams","volume":"166","author":"Manley","year":"2015","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.ajo.2021.06.034_bib0051","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamapediatrics.2015.2175","article-title":"Prognostic factors for poor cognitive development in children born very preterm or with very low birth weight: a systematic review","volume":"169","author":"Linsell","year":"2015","journal-title":"JAMA Pediatr"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421003639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421003639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:47:18Z","timestamp":1757598438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421003639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S0002939421003639"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.06.034","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive Outcomes Following Intravitreal Bevacizumab for Retinopathy of Prematurity: 4- to 6-Year Outcomes in a Prospective Cohort","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}